COMP <GO>

LUCD vs LNSR // EV/EBITDA & P/E VALUATION

Lucid Diagnostics Inc. (NASDAQ) VS. LENSAR Inc. (NASDAQ) • 15-METRIC TALLY: LUCD 2 — LNSR 1

■ METRIC PARITY

LAST: $0.41 (+0.37%) • MKT CAP: $82.3M

valuation

—

LAST: $5.67 (-2.91%) • MKT CAP: $71.7M

valuation

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LUCD VS. LNSR) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	LUCD	LNSR	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	39.40%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	-20.33%	—	TIE	/fcf-yield <GO>
Operating Margin	—	-47.60%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-60.00%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	12.40%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	0.20	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	2/9	4/9	-2.00	LNSR	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	35.4	34.6	+0.80	LUCD	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$82.3M	$71.7M	$10.5M	LUCD	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	LUCD REV	LNSR REV	LUCD GROSS %	LNSR GROSS %	LUCD FCF	LNSR FCF
FY 2025	$139.0M	$51.7M	—	39.4%	-$46.7M	-$14.9M
FY 2024	$4.3M	$46.0M	-50.0%	39.9%	-$44.4M	-$2.4M
FY 2023	$2.4M	$35.7M	—	—	-$32.8M	-$9.7M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

LUCD // BETA —

LNSR // BETA —